MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Noradrenaline treatment of apathy and impulsivity in participants with Progressive Supranuclear Palsy syndromes (NORAPS). A Phase II clinical trial – ISRCTN99462035.

    R. Durcan, J. Rowe (Cambridge, United Kingdom)

    Objective: The NORAPS Phase II clinical trial seeks to demonstrate safety, tolerability and efficacy of atomoxetine in Progressive Supranuclear Palsy (PSP). Background: PSP is a…
  • 2024 International Congress

    Loneliness Relates to Gait Over Other Features of Parkinsonism

    D. Gonzalez, R. Wilson, M. Tosin, C. Goetz (Chicago, USA)

    Objective: To assess the relationship between loneliness and facets of parkinsonism in community-based samples. Background: Loneliness increases the risk of mortality, dementia, depression, and motor…
  • 2024 International Congress

    eHealth Technologies for People with Parkinson’s: Acceptance & Implications

    J. Stuempel, V. Fleckenstein, J. Hohn, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)

    Objective: To investigate the impact of eHealth on Parkinson's care, focusing on technology acceptance and examining ethical, legal, social, and medical aspects of wearables. Background:…
  • 2024 International Congress

    Clinical correlates of apathy in Parkinson´s disease

    J. Arena, L. Fiorentini, C. Obarrio, M. Merello (Buenos Aires, Argentina)

    Objective: To investigate the demographic and clinical correlates of apathy in a group of patients from a Movement Disorders clinic in Latin America. Background: Apathy…
  • 2024 International Congress

    Examining the Effects of Deep Brain Stimulation on Speech in Parkinson’s Disease

    H. Kabakoff, A. Mogilner, M. Pourfar, A. Flinker (Brooklyn, USA)

    Objective: The current goal is to use pilot data to explain speech changes in patients with Parkinson’s disease (PD) who have Deep Brain Stimulation (DBS)…
  • 2024 International Congress

    Comparison of Gastrointestinal Dysfunction in Early-onset and Late-onset Parkinson’s Disease

    C. Arora, N. Kamble, V. Holla, R. Mahale, R. Yadav, P. Pal (BENGALURU, India)

    Objective: To compare the gastrointestinal dysfunction in patients with early-onset Parkinson’s disease (EOPD) and late-onset Parkinson’s disease (LOPD). Background: Gastrointestinal dysfunction is one of the…
  • 2024 International Congress

    Unmet Motor and Nonmotor Needs of People with Parkinson’s in the Final Year of Life

    K. Rukavina, M. Al-Agil, K. Poplawska-Domaszewicz, S. Veronese, D. Oliver, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To assess main issues People with Parkinson’s (PD, PwP) wished to discuss at clinical consultations with movement disorders specialists during the final year of…
  • 2024 International Congress

    Pump Priming a Parkinson’s Rapid Response Physiotherapy and Occupational Therapy Service

    F. Lindop, R. Skelly, B. Denney, S. Voyce (Derby, United Kingdom)

    Objective: To establish a Parkinson's (PD) rapid therapy service offering in-reach to wards and outreach into the community. The aim is to improve overall care,…
  • 2024 International Congress

    Quality Improvement of Careflow Referrals to Parkinson’s Disease Nurse Specialist (PDNS) Service at East Kent Hospitals University Foundation Trust (EKHUFT)

    N. Natarajan, H. Hassan, M. Ahmed, N. Patel, K. Lauckaite (Solihull, United Kingdom)

    Objective: The aim of this study was to increase the proportion of appropriate referrals to 70% using an online banner. A secondary objective was to…
  • 2024 International Congress

    Exploring the Root of Cognitive Decline in People Living with Parkinson’s Disease: An Analysis of MoCA Scores, Neuropsychiatric Symptoms, and Patient-Reported Outcomes

    K. Sánchez-Ramírez, S. Arechavala-Lopez, D. Romero-Terán, A. Hernández-Medrano, M. Medina-Pérez, A. Cervantes-Arriaga, M. Rodríguez-Violante (CULIACAN, Mexico)

    Objective: To evaluate cognitive decline in people living with PD (PwP), to determine to which degree different neuropsychiatric symptoms are risk factors for cognitive decline…
  • « Previous Page
  • 1
  • …
  • 243
  • 244
  • 245
  • 246
  • 247
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley